Screener
Tarsus Pharmaceuticals, Inc. TARS Stock options issued and outstanding under the 2016 Plan (shares)
Stock options issued and outstanding under the 2016 Plan (shares) at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept tars:CommonStockCapitalSharesReservedForFutureIssuanceEffectOfStockOptionsIssuedAndOutstanding.
The source filing: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:25 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001819790-26-000064
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Pre-funded warrants to purchase common stock | 312,500 | 312,500 |
| Equity award plans: | ||
| Common stock awards reserved for future issuance under the 2020 and 2016 Plans | 7,950,712 | 7,044,164 |
| Common stock awards reserved for future issuance under the 2020 ESPP | 3,195,262 | 2,796,609 |
| Stock options issued and outstanding (unvested and vested) under the 2020 and 2016 Plans | 5,536,833 | 5,231,125 |
| Restricted stock units issued and outstanding (unvested) under the 2020 Plan | 1,574,015 | 1,756,329 |
| Performance stock units issued and outstanding (unvested) under the 2020 Plan | 706,478 | 724,793 |
| Total shares of common stock reserved | 19,275,800 | 17,865,520 |
Item 1. Financial Statements
FAQ
- What is Tarsus Pharmaceuticals, Inc.'s stock options issued and outstanding under the 2016 plan (shares)?
- Tarsus Pharmaceuticals, Inc. (TARS) reported stock options issued and outstanding under the 2016 plan (shares) of $5.54M in Q2 2026.
- How has Tarsus Pharmaceuticals, Inc.'s stock options issued and outstanding under the 2016 plan (shares) changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s stock options issued and outstanding under the 2016 plan (shares) increased by 4.1% year-over-year, from $5.32M to $5.54M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s stock options issued and outstanding under the 2016 plan (shares)?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s stock options issued and outstanding under the 2016 plan (shares) has grown at a 23.3% compound annual growth rate (CAGR), from $1.84M to $5.23M.
- What does stock options issued and outstanding under the 2016 plan (shares) mean?
- Stock options issued and outstanding under the 2016 Plan (shares) as reported by Tarsus Pharmaceuticals, Inc. Common Stock.
Ask your AI about Tarsus Pharmaceuticals, Inc.'s stock options issued and outstanding under the 2016 plan (shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude